Did the PMPRB censor CHPI's Submission to its Draft Guidelines Consultation?

Download Full Article Article Brief



The Patented Medicine Prices Review Board (PMPRB) recently conducted a public consultation regarding the pending implementation of new draft regulatory guidelines. According to the consultation website “Extensive feedback was received and all written submissions are now available on the PMPRB website.”. However, as of April 6, 2020 this website has not posted a submission made by the Canadian Health Policy Institute (CHPI). CHPI has conveyed to the Minister of Health our serious concern that the PMPRB has censored its public consultation by excluding CHPI’s submission from the list of posted submissions on the consultation website. This action by the PMPRB consultation is a violation of the democratic process that such a consultation is supposed to represent. It is also inconsistent with the government’s commitment to evidence based policy making. CHPI is making our submission available here.

Subscribe image

CHP blogazine